Implications of COVID-19 control measures for diet and physical activity, and lessons for addressing other pandemics facing rapidly urbanising countries.


Journal

Global health action
ISSN: 1654-9880
Titre abrégé: Glob Health Action
Pays: United States
ID NLM: 101496665

Informations de publication

Date de publication:
31 12 2020
Historique:
entrez: 2 9 2020
pubmed: 2 9 2020
medline: 18 9 2020
Statut: ppublish

Résumé

At the time of writing, it is unclear how the COVID-19 pandemic will play out in rapidly urbanising regions of the world. In these regions, the realities of large overcrowded informal settlements, a high burden of infectious and non-communicable diseases, as well as malnutrition and precarity of livelihoods, have raised added concerns about the potential impact of the COVID-19 pandemic in these contexts. COVID-19 infection control measures have been shown to have some effects in slowing down the progress of the pandemic, effectively buying time to prepare the healthcare system. However, there has been less of a focus on the indirect impacts of these measures on health behaviours and the consequent health risks, particularly in the most vulnerable. In this current debate piece, focusing on two of the four risk factors that contribute to >80% of the NCD burden, we consider the possible ways that the restrictions put in place to control the pandemic, have the potential to impact on dietary and physical activity behaviours and their determinants. By considering mitigation responses implemented by governments in several LMIC cities, we identify key lessons that highlight the potential of economic, political, food and built environment sectors, mobilised during the pandemic, to retain health as a priority beyond the context of pandemic response. Such whole-of society approaches are feasible and necessary to support equitable healthy eating and active living required to address other epidemics and to lower the baseline need for healthcare in the long term.

Identifiants

pubmed: 32867606
doi: 10.1080/16549716.2020.1810415
pmc: PMC7480567
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1810415

Subventions

Organisme : Medical Research Council
ID : MC_UU_00006/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12015/1
Pays : United Kingdom

Références

J Urban Health. 2016 Aug;93(4):722-30
pubmed: 27184571
Lancet. 2020 Mar 21;395(10228):931-934
pubmed: 32164834
Prev Med Rep. 2015 Aug 14;2:720-4
pubmed: 26844143
Eur J Clin Nutr. 2020 Aug;74(8):1117-1121
pubmed: 32313188
Obesity (Silver Spring). 2020 Jun;28(6):1008-1009
pubmed: 32227671
J Urban Health. 2020 Jun;97(3):348-357
pubmed: 32333243
Eur J Prev Cardiol. 2020 Jun;27(9):906-908
pubmed: 32270698
Environ Sci Technol. 2011 Mar 1;45(5):1761-72
pubmed: 21291246

Auteurs

Tolu Oni (T)

MRC Epidemiology Unit, University of Cambridge , Cambridge, UK.
Research Initiative for Cities Health and Equity (RICHE), School of Public Health and Family Medicine, University of Cape Town , Cape Town, South Africa.

Lisa K Micklesfield (LK)

South African MRC/Wits Developmental Pathways for Health Research Unit (DPHRU, University of Witwatersrand , Johannesburg, South Africa.

Pamela Wadende (P)

School of Education and Human Resource Development, Kisii University , Kisii, Kenya.

Charles O Obonyo (CO)

Centre for Global Health Research, Kenya Medical Research Institute , Kisusmu, Kenya.

James Woodcock (J)

MRC Epidemiology Unit, University of Cambridge , Cambridge, UK.

Ebele R I Mogo (ERI)

MRC Epidemiology Unit, University of Cambridge , Cambridge, UK.

Feyisayo A Odunitan-Wayas (FA)

Research Centre for Health through Physical Activity, Lifestyle and Sport (HPALS, University of Cape Town , Cape Town, South Africa.

Felix Assah (F)

Health of Populations in Transition (HoPiT, University of Yaoundé , Yaounde, Cameroon.

Lambed Tatah (L)

MRC Epidemiology Unit, University of Cambridge , Cambridge, UK.
Health of Populations in Transition (HoPiT, University of Yaoundé , Yaounde, Cameroon.

Louise Foley (L)

MRC Epidemiology Unit, University of Cambridge , Cambridge, UK.

Clarisse Mapa-Tassou (C)

Health of Populations in Transition (HoPiT, University of Yaoundé , Yaounde, Cameroon.

Divya Bhagtani (D)

MRC Epidemiology Unit, University of Cambridge , Cambridge, UK.

Amy Weimann (A)

Research Initiative for Cities Health and Equity (RICHE), School of Public Health and Family Medicine, University of Cape Town , Cape Town, South Africa.

Camille Mba (C)

MRC Epidemiology Unit, University of Cambridge , Cambridge, UK.
Health of Populations in Transition (HoPiT, University of Yaoundé , Yaounde, Cameroon.

Nigel Unwin (N)

MRC Epidemiology Unit, University of Cambridge , Cambridge, UK.

Anna Brugulat-Panés (A)

MRC Epidemiology Unit, University of Cambridge , Cambridge, UK.

Karen J Hofman (KJ)

South African MRC Centre for Health Economics and Decision Science (PRICELESS SA), Faculty of Health Sciences, School of Public Health, University of Witwatersrand , Johannesburg, South Africa.

Joanne Smith (J)

Caribbean Institute for Health Research, The University of West Indies , Kingston, Jamaica.

Marshall Tulloch-Reid (M)

Caribbean Institute for Health Research, The University of West Indies , Kingston, Jamaica.

Agnes Erzse (A)

South African MRC Centre for Health Economics and Decision Science (PRICELESS SA), Faculty of Health Sciences, School of Public Health, University of Witwatersrand , Johannesburg, South Africa.

Maylene Shung-King (M)

Research Initiative for Cities Health and Equity (RICHE), School of Public Health and Family Medicine, University of Cape Town , Cape Town, South Africa.

Estelle V Lambert (EV)

Research Centre for Health through Physical Activity, Lifestyle and Sport (HPALS, University of Cape Town , Cape Town, South Africa.

Nicholas J Wareham (NJ)

MRC Epidemiology Unit, University of Cambridge , Cambridge, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH